金陵药业 (000919.SZ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

17.0x

Market Cap

CNY 4.05B

MomentumView details →

1D Return

−1.96%

YTD Return

−17.48%

RSI (14)

48.2

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

17.0x

Market Cap

CNY 4.05B

RSI (14)

48.2

MomentumView details →

1D Return

−1.96%

YTD Return

−17.48%

ProfitabilityView details →

Gross Margin

21.40%

Net Margin

1.87%

EBITDA Margin

7.55%

ROE (TTM)

1.55%

ROA (TTM)

0.98%

Asset Turnover

0.52x

GrowthView details →

Revenue YoY

−2.76%

EPS YoY

+213.12%

FCF YoY

+375.63%

Revenue CAGR 3Y

+6.18%

EPS CAGR 3Y

−25.41%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.05x

Current Ratio

3.93x

Quick Ratio

3.70x

Div Yield

1.52%

Div Rate

CNY 0.10

Div Growth 1Y

+0.00%

Financials snapshotView financials →

Revenue (TTM)

3.16B

Net Income (TTM)

58.94M

Op. CF (TTM)

230.92M

Latest newsMore news →

Jinling Pharmaceutical announced its first-half 2026 results: revenue of 1.584 billion yuan, down 1.04% year-on-year; net profit attributable to shareholders of 50.3825 million yuan, up 4.24% year-on-year.8d ago

Jinling Pharmaceutical's Fuzhou Meifeng Pharmaceutical Factory received an acceptance notice from the National Medical Products Administration for its marketing authorization application for ferric carboxymaltose injection.36d ago

Similar companies

长联科技301618.SZ 万胜智能300882.SZ 立高食品300973.SZ 广信材料300537.SZ 亚太药业002370.SZ 博汇股份300839.SZ Find similar companies →

Latest newsMore news →

Jinling Pharmaceutical announced its first-half 2026 results: revenue of 1.584 billion yuan, down 1.04% year-on-year; net profit attributable to shareholders of 50.3825 million yuan, up 4.24% year-on-year.8d ago Jinling Pharmaceutical's Fuzhou Meifeng Pharmaceutical Factory received an acceptance notice from the National Medical Products Administration for its marketing authorization application for ferric carboxymaltose injection.36d ago